Newsroom

Industry News

6 Sep

Arch Therapeutics to Provide Corporate Update at the 19th Annual Rodman & Renshaw Global Investment Conference In New York City September 10-12, 2017

FRAMINGHAM, Mass., Sept. 06, 2017 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company at the 19th Annual Rodman & Renshaw Global Investment Conference. The conference is being held...

Read more

6 Sep

Catalyst Biosciences Announces Positive Factor IX Clinical Data

— CB 2679d/ISU304 is approximately 22 times more potent than current hemophilia B therapy — SOUTH SAN FRANCISCO, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (CBIO), today announced positive clinical data from the first Cohort of its ongoing Phase 1/2 proof-of-concept clinical trial in individuals with...

Read more

6 Sep

Mateon Therapeutics to Present at the 19th Annual Rodman and Renshaw Global Investment Conference on September 12, 2017

SOUTH SAN FRANCISCO, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing vascular disrupting agents for the treatment of orphan oncology indications, today announced it will be featured as a presenting company at the 19th Annual Rodman & Renshaw Global Investment Conference. Mateon’s presentation...

Read more

5 Sep

OncoSec Appoints Industry Veteran Annalisa Jenkins MBBS, FRCP to Board of Directors

Former Head of Global Research and Development for Merck Serono and Head of Global Medical Affairs of Bristol-Myers Squibb brings biopharma drug development, fundraising and M&A experience to OncoSec SAN DIEGO, Sept. 5, 2017 /PRNewswire/ — OncoSec Medical Incorporated (“OncoSec” or the “Company” (ONCS)), a company developing DNA-based intratumoral cancer...

Read more

5 Sep

Onconova Therapeutics to Participate in Two Investor Conferences in September

NEWTOWN, Pa., Sept. 05, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), announced that they will present at the Rodman & Renshaw 19th Annual Global Investment Conference...

Read more

31 Aug

Trovagene Announces Participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City September 10-12, 2017

SAN DIEGO, Aug. 31, 2017 /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced it will be featured as a presenting company at the 19th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC.  The conference is being held on September 10-12, 2017 at Lotte New York Palace Hotel...

Read more

Page 4 of 255« First...23456...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address